All Activities
Choose from the criteria below to find an activity that fits you best.
Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information ►
Featured Activity
Contemporary Evaluation and Management of Lung Cancer Targeted Therapies
Learn about treatment options, treatment failure, associated adverse effects and more.
Choose from the criteria below to find an activity that fits you best.
SHOW SEARCH
![]() |
![]() |
This activity can also serve as BCIDP recertification credit hours!![]() |
|
SIDP Members login to SIDP to verify your membership, then follow the members only link to receive discounts ![]() |
![]() |
A product of the Society of Infectious Diseases Pharmacists Education Center (SIDPEC) |
NOTE: If you attended this live CE activity that was held on November 14, 2020 at the SIDP Annual Meeting AND received CE credit (i.e. a pharmacist CE statement with ACPE Universal Activity Number 0221-9999-20-518-L01-P), you are NOT eligible to also receive CE credit for this home-study activity.
This activity will focus on antifungals and discuss evidence regarding their use
on invasive candidiasis in critically ill patients. Non-culture diagnostic techniques
will also be evaluated.
This is a featured CE activity on the Society of Infectious Diseases Pharmacists Education
Center (SIDPEC) website. SIDPEC is the educational hub of the Society of Infectious
Diseases Pharmacists (SIDP). The SIDPEC portal provides educational activities on
infectious disease pharmacotherapy for clinical pharmacists, health‐systems
pharmacists, community pharmacists, and other allied‐health disciplines.
The target audience for this activity is pharmacists. At the completion of this activity, the participant will be able to:
Gregory Eschenauer, PharmD
University of Michigan College of Pharmacy
Release Date: November 14, 2020
Expiration Date: November 14, 2023
BCIDP Expiration Date: November 14, 2021
This activity is jointly provided by ProCE, LLC and the Society
of Infectious Diseases Pharmacists. ProCE, LLC is accredited by the Accreditation
Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE
Universal Activity Number 0221-9999-20-518-H01-P has been assigned to this home-study
knowledge-based activity. This activity is approved for 1.0 contact hour (0.1 CEU)
in states that recognize ACPE providers. The activity is provided at no cost to participants.
Statements of completion will be issued online at www.ProCE.com upon completion of
the evaluation and post-test with a score of 70% or higher. Proof of completion will
be posted in NABP CPE Monitor profiles. No partial credit will be given.
The Society of Infectious Diseases Pharmacists (SIDP) is accredited
by the Board of Pharmacy Specialties (BPS) as a provider of board certified infectious
diseases pharmacist (BCIDP) credit. A BCIDP statement of credit will be issued online
upon successful completion of a post-test and online evaluation. The post-test must
be successfully completed in only one attempt. No partial credit will be given. BCIDP
accreditation begins 11/14/2020 for this activity and is available for one year from
this date.
Recertification Criteria for Infectious Diseases Pharmacy: BCIDP recertifying via continuing education are required to earn 100 hours of continuing education credit provided by the joint program offered by the Society of Infectious Diseases Pharmacists (SIDP), American College of Clinical Pharmacy (ACCP) and/or the American Society of Health-System Pharmacists (ASHP). Infectious Diseases Pharmacy Specialty Recertification Courses offered by any of the approved providers may only be completed for recertification credit up to two times, in nonconsecutive years, during the 7-year recertification cycle. Candidates should note that there are expiration dates associated with earning BPS recertification credit. BPS will only award recertification credit for modules based on the completion and submission date of the post-test assessment. For example, a module completed and submitted on October 20 of a particular year will only be credited for that year, even if the due date of the post-test is in January of the following year. View all recertification criteria on the BPS website at https://www.bpsweb.org/recertification/recertification-by-continuing-education
It is the policy of ProCE, LLC to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed in this activity. Gregory Eschenauer is a consultant for Wolters Kluwer (Lexi-Comp).
No external support has been received for this activity.
The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.